Additionally, the involvement of ARRB1 in the Wnt/beta-catenin signaling pathway, a hallmark driver of CRC and the most representative canonical signaling pathways [50], suggests its potential as an early biomarker for the development of adenomas [51]. Here, ARRB1 is linked to adenoma.